06:51 AM EDT, 07/10/2026 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reaffirmed its fiscal 2026 financial guidance, leaving unchanged the outlook issued with its first-quarter results, citing a regulatory filing on Friday.
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations,
you may see comments from our Community Managers.